Bafna Pharma Income Statement

Quarterly

Yearly

home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
201820192020
EBITDA-4-131
EBIT-8-16-2
Earning Per Share0-11-15
Expenses825741
Net Profit-17-18-24
Net Profit Margin-36-42-58
Operating Profit Margin-8-293
Profit Before Tax-15-17-24
Dividends Per Share000
Operation Revenue794443

Peer Comparison (in ₹.Cr.)

CompanyYearEBITEBITDANet ProfitNet WorthProfit Before Tax
2023008,560.84NA9,408.43
2023002,835.49NA4,038.35
202300372.90NA385.50
202300103.87NA140.39
20221,257.602,182.90978.507,628.101,190
The EBITDA of Bafna Pharma is 1 as of 9/25/2023
home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
20162017201720172017
Operating Activities1-1-1-1-1
Investing Activities-0-5-5-5-5
Financing Activities-16666
Others00000
Net Cash Flow-0-0-0-0-0

Peer Comparison (in ₹.Cr.)

CompanyYearOperating ActivitiesInvesting ActivitiesFinancing ActivitiesNet Cash Flow
20234,959.33-7,943.682,376.07-608.28
20223,325.90-1,871.88-1,599.79-145.77
2023723.95-447.59-261.9614.40
2020140.90-44.50-38.5557.85
2017640-498.50-177.50-36
The cash flow from Operating Activities of Bafna Pharma is -1 as of 9/25/2023